| |
| |
|
| Insider
Information: |
Skolnick Phil |
| Relationship: |
Chief Scientific Officer |
| City: |
Hackensack |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -40.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Chief Scientific Officer |
2023-03-02 |
0 |
2018-10-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-07-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-07-01 |
4 |
AS |
$13.20 |
$103,026 |
D/D |
(7,805) |
2,195 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-07-02 |
4 |
AS |
$13.16 |
$28,886 |
D/D |
(2,195) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-08-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-08-01 |
4 |
AS |
$11.66 |
$98,434 |
D/D |
(8,442) |
1,558 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-08-02 |
4 |
AS |
$11.30 |
$17,605 |
D/D |
(1,558) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-09-03 |
4 |
AS |
$14.08 |
$105,684 |
D/D |
(7,506) |
2,494 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-09-03 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-09-04 |
4 |
AS |
$14.37 |
$35,839 |
D/D |
(2,494) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-10-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-10-01 |
4 |
AS |
$14.79 |
$107,804 |
D/D |
(7,289) |
2,711 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-10-02 |
4 |
AS |
$14.57 |
$16,056 |
D/D |
(1,102) |
1,609 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-10-03 |
4 |
AS |
$14.27 |
$22,960 |
D/D |
(1,609) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-11-01 |
4 |
AS |
$15.10 |
$108,735 |
D/D |
(7,201) |
2,799 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-11-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-11-04 |
4 |
AS |
$15.28 |
$4,569 |
D/D |
(299) |
2,500 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-11-05 |
4 |
AS |
$14.89 |
$37,225 |
D/D |
(2,500) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-12-02 |
4 |
AS |
$14.17 |
$36,346 |
D/D |
(2,565) |
7,435 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-12-02 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-12-03 |
4 |
AS |
$13.93 |
$63,772 |
D/D |
(4,578) |
2,857 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-12-05 |
4 |
AS |
$13.74 |
$28,263 |
D/D |
(2,057) |
800 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2019-12-06 |
4 |
AS |
$13.34 |
$10,672 |
D/D |
(800) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2020-01-02 |
4 |
AS |
$14.08 |
$9,856 |
D/D |
(700) |
9,300 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2020-01-02 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2020-01-06 |
4 |
AS |
$13.80 |
$7,107 |
D/D |
(515) |
8,785 |
0 |
% |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
